Aerospace and defense company Cadre (NYSE: CDRE) met Wall Street’s revenue expectations in Q1 CY2026, with sales up 19.5% year on year to $155.4 million. The company’s full-year revenue guidance of $747 million at the midpoint came in 0.9% above analysts’ estimates. Its non-GAAP profit of $0.18 per share was 98.7% above analysts’ consensus estimates.

Is now the time to buy CDRE? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

Cadre’s first quarter results for 2026 were marked by robust top-line growth, as management highlighted a 19% year-over-year sales increase driven by continued demand for its law enforcement, military, and nuclear safety products. However, a significant decline in operating margin drew concern, with CEO Warren Kanders noting that certain product mix headwinds—especially in the armor and nuclear segments—offset the benefits of strong recurring demand. President Brad E. Williams also referenced softness in the company’s distribution segment, specifically among third-party discretionary products, while emphasizing that demand for Cadre’s core safety offerings remained resilient. Management acknowledged these mixed dynamics, with Kanders stating, “we are watching [distribution softness] from that standpoint…but from a product segment perspective, we look good.”

Looking ahead, Cadre’s 2026 guidance is underpinned by a record orders backlog and expectations of sequential revenue and margin improvement, supported by recent acquisitions and strong market demand. Management is focused on integrating the TIER Tactical and Alien Gear Holsters acquisitions, which are anticipated to drive new product synergies and bolster the company’s position in both public safety and nuclear markets. CFO Blaine Browers explained that the backlog growth, particularly the $87 million blast attenuation seat contract, provides confidence in revenue conversion for the remainder of the year. Williams noted that the company is closely monitoring government budget trends and remains committed to disciplined capital allocation, stating, “We will target deals that broaden our product range and/or increase our customer wallet share.”

Key Insights from Management’s Remarks

Management attributed revenue growth to recurring demand across core safety categories, record backlog levels, and targeted acquisitions, while acknowledging margin compression from product mix headwinds.

• Orders backlog at all-time high: Cadre exited the quarter with a record $355 million in orders backlog, reflecting both organic growth—driven by contracts like the General Dynamics blast attenuation seat deal—and contributions from the TIER Tactical acquisition. Management views this backlog as a strong indicator of continued demand into the year.
• Distribution segment softness: Williams noted the first signs of weakness in company-owned distribution since the pandemic and “defund the police” period, particularly in third-party discretionary product categories. However, demand for Cadre’s own safety products remains stable, supporting the company’s recurring revenue base.
• Product mix impacted margins: The quarter’s lower operating margin was attributed to a heavier mix of lower-margin products in the armor and nuclear segments. Browers indicated this was consistent with expectations based on the backlog profile and expects improvement as higher-margin orders convert later in the year.
• M&A strategy accelerates: Cadre completed the acquisitions of TIER Tactical and Alien Gear Holsters, expanding its portfolio and manufacturing capabilities. The TIER integration is progressing well, with early projects underway in product development and cross-brand synergies. Alien Gear, acquired via bankruptcy auction, is expected to benefit from operational improvements and market positioning alongside Safariland.
• End market tailwinds: Management cited heightened geopolitical tensions, increased global defense spending, and government prioritization of public safety and nuclear cleanup as long-term demand drivers. Williams highlighted that the U.S. Department of Energy’s budget shifts are expected to boost demand for Cadre’s nuclear safety products, especially in defense-related applications.

Drivers of Future Performance

Management expects revenue and adjusted EBITDA growth to be driven by strong backlog conversion, recent acquisitions, and resilient demand across core markets amid evolving government budgets.

• Backlog conversion supports growth: The company anticipates that the majority of its record orders backlog will convert to revenue within the year, excluding larger contracts like the blast attenuation seat deal, which will extend into future years. This backlog is expected to underpin both revenue and adjusted EBITDA growth in the coming quarters.
• Acquisition integration and product synergies: Successful integration and ramp-up of TIER Tactical and Alien Gear are forecasted to contribute incremental sales and margin expansion, particularly as manufacturing improvements and cross-brand initiatives take hold. Management emphasized leveraging shared processes to enhance both operational efficiency and market reach.
• Monitoring government and end-market trends: While public safety and nuclear segments remain resilient, Cadre is monitoring evolving government budgets, distribution segment softness, and environmental management spending. Changes in U.S. federal and Department of Energy allocations, especially toward defense applications, could influence product demand and strategic focus.

Catalysts in Upcoming Quarters

In the coming quarters, the StockStory team will monitor (1) the pace of integration and performance improvements in TIER Tactical and Alien Gear Holsters, (2) the conversion rate of Cadre’s record orders backlog into revenue—particularly in armor, duty gear, and nuclear segments, and (3) updates on government defense and nuclear budgets, which could impact demand for core products. Evolving trends in public safety funding and further M&A activity will also be important indicators of execution.

Cadre currently trades at $27.24, down from $31.42 just before the earnings. In the wake of this quarter, is it a buy or sell? Find out in our full research report (it’s free).

High Quality Stocks for All Market Conditions

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don't just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn't over. Find out which 9 stocks made the cut this week - FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.